SPHK1 and prostate carcinoma: Similar to the previous findings in PC3 and DU145 prostate cancer cells16, docetaxel did not decrease the levels of P70S6K phosphorylation (a marker for mTOR activity), SK1 mRNA or activity, but rather insignificantly increased them (Fig. 2).